Author: creacionmx

SPRING: A New Trial to Evaluate Tipranavir in Heterogeneous Treatment-Experienced HIV Populations

The NEFA Study: Results at Three Years

Three-year Extended Follow-up of the 2NN Study: Nevirapine versus Efavirenz

New Trials Comparing Protease Inhibitors and Nonnucleoside Analogs will Assess Reductions in Cardiovascular Risk Besides Antiviral Efficacy in First-line Therapies

Warning on Hepatotoxicity of Darunavir

New Resistance Score for Tipranavir

Clinical Impact of Minor Drug-resistant Virus Populations on Treatment Response

HIV Vaccines: What are we Learning from Failure?

Multicentre Inter-cohort Studies – Reliable Responses for HIV Disease Management?

Tightening of Peer Review Standards